Hybrid procedures have proven clinical utility and are the wave of the future

Circulation

Volumn 125, Issue 20, 2012, Pages 2492-2503

  Shannon, Joanne ^a,b,c   Colombo, Antonio ^a,b   Alfieri, Ottavio ^b  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANGRELOR; CLOPIDOGREL; HEPARIN; HIRULOG; PRASUGREL; TICAGRELOR;

ARTICLE; ATHEROSCLEROSIS; BARE METAL STENT; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; GOLD STANDARD; HEART MUSCLE REVASCULARIZATION; HEART VALVE REPLACEMENT; HUMAN; HYBRID CORONARY REVASCULARIZATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; PATIENT SATISFACTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOLOGY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GRAFT SURVIVAL; HUMANS; OPERATING ROOMS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; ROBOTICS; TREATMENT OUTCOME;

EID: 84861302907     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.041186     Document Type: Article

References (69)

1. Coronary Artery Surgery Study (CASS): a randomized trial of coronary bypass surgery: survival data. Circulation. 1983;68:939-950.
2. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.
3. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. BARI trial: the final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49:1600-1606.
4. Popma JJ, Nathan S, Hagberg RC, Khabbaz KR. Hybrid myocardial revascularization: an integrated approach to coronary revascularization. Catheter Cardiovasc Interv. 2010;75:S28-S34.
5. Hayward PA, Buxton BF. Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits. Ann Thorac Surg. 2007;84:795-799.
6. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004;77:93-101.
7. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT; PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled Trial. JAMA. 2005;294:2446-2454.
8. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, Staples JR, Glas KE, Marshall JJ, Leimbach ME, McCall SA, Petersen RJ, Bailey DE, Weintraub WS, Guyton RA. Off-pump vs. conventional coronary artery bypass grafting: early and 1-year graft patency, cost and quality of life outcomes: a randomized trial. JAMA. 2004;291:1841-1849.
9. Serruys PW, Morice M, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
10. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231.
11. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
12. Serruys PW, Kutryk MJ, Ong AT. Coronary artery stents. N Engl J Med. 2006;354:483-495.
13. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42.
14. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111: 3435-3442.
15. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Muller R, Regar E, Degertekin M, Ligthart JM, Disco C, Backx B, Russell ME. TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slowrelease polymer formulation. Circulation. 2003;107:559-564.
16. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med. 1997;336:817-822.
17. Kastrati A, Schomig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428-1436.
18. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293-1304.
19. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese V, Kapoor JR, Ardehali R, Owens DK, Hlatky MA. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147:703-716.
20. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet. 2009;373:1190-1197.
21. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RSD, Carlson RE, Jones RH. Drug-eluting stents vs. coronary artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331-341.
22. Cohen DJ, Van Hout B, Serruys PW, Mohr FW, Macaya C, den Heijer P, Vrakking MM, Wang K, Mahoney EM, Audi S, Leadley K, Dawkins KD, Kappetein AP; Synergy Between PCI With TAXUS and Cardiac Surgery Investigators. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 2011;364:1016-1026.
23. DeRose JJ. Current state of integrated "hybrid" coronary revascularization. Semin Thorac Cardiovasc Surg. 2009;21:229-236.
24. Zenati M, Cohen HA, Feldman MD, Chough SH, Courcoulas AP, Smith CA, Lee JS, Izzo M, Counihan PJ, Jafar MZ, Griffith BP. Improved results of minimally invasive coronary artery bypass in Parsonnet very high risk patients [abstract]. Circulation. 1997;96(suppl I):I-682.
25. Zenati M, Domit TM, Saul M, Gorcsan J 3rd, Katz WE, Hudson M, Courcoulas AP, Griffith BP. Resource utilization for minimally invasive direct and standard coronary artery bypass. Ann Thorac Surg. 1997; 63(suppl):S84-S87.
26. Angelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularization. Lancet. 1996;347:757-758.
27. Lloyd CT, Calafiore AM, Wilde P, Ascione R, Paloscia L, Monk CR, Angelini GD. Integrated left anterior small thoracotomy and angioplasty for coronary artery revascularization. Ann Thorac Surg. 1999;68: 908-912.
28. Lewis BS, Porat E, Halon DA, Ammar R, Flugelman MY, Khader N, Merdler A, Weisz G, Uretzky G. Same-day combined coronary angioplasty and minimally invasive coronary surgery. Am J Cardiol. 1999;84: 1246-1247.
29. Zenati M, Cohen HA, Griffith BP. Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Surg. 1999;117:439-446.
30. Isomura T, Suma H, Horii T, Sato T, Kobashi T, Kanemitsu H. Minimally invasive coronary artery revascularization: off-pump bypass grafting and the hybrid procedure. Ann Thorac Surg. 2000;70:2017-2022.
31. Wittwer T, Cremer J, Klima U, Wahlers T, Haverich A. Myocardial "hybrid" revascularization: intermediate results of an alternative approach to multivessel coronary artery disease. J Thorac Cardiovasc Surg. 1999; 118:766-767.
32. De Canniere D, Jansens JL, Goldschmidt-Clermont P, Barvais L, Decroly P, Stoupel E. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. Am Heart J. 2001;142:563-570.
33. Hu S, Li Q, Gao P, Xiong H, Zheng Z, Li L, Xu B, Gao R. Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease. Ann Thorac Surg. 2011;91:432-439.
34. Stahl KD, Boyd WD, Vassiliades TA, Karamanoukian HL. Hybrid robotic coronary artery surgery and angioplasty in multivessel coronary artery disease. Ann Thorac Surg. 2002;74:S1358-1362.
35. Davidavicius G, Van Praet F, Mansour S, Casselman F, Bartunek J, Degrieck I, Wellens F, De Geest R, Vanermen H, Wijns W, De Bruyne B. Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve-guided percutaneous coronary intervention. Circulation. 2005;112(suppl I):I-317-I-322.
36. Katz MR, Van Praet F, de Canniere D, Murphy D, Siwek L, Seshadri-Kreaden U, Friedrich G, Bonatti J. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation. 2006;114:I473-I476.
37. Vassiliades TA Jr, Douglas JS, Morris DC, Block PC, Ghazzal Z, Rab ST, Cates CU. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. J Thorac Cardiovasc Surg. 2006;131:956-962.
38. Holzhey DM, Jacobs S, Mochalski M, Merk D, Walther T, Mohr FW, Falk V. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg. 2008;86:1856-1860.
39. Kiaii B, McClure S, Stewart P, Rayman R, Swinamer SA, Suematsu Y, Fox S, Higgins J, Albion C, Kostuk WJ, Almond D, Sridhar K, Teefy P, Jablonsky G, Diamantouros P, Dobkowski WB, Jones P, Bainbridge D, Iglesias I, Murkin J, Cheng D, Novick RJ. Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. J Thorac Cardiovasc Surg. 2008;136:702-708.
40. Bonatti J, Schachner T, Bonaros N, Jonetzko P, Ohlinger A, Ruetzler E, Kolbitsch C, Feuchtner G, Laufer G, Pachinger O, Friedrich G. Simultaneous Hybrid COronary Revascularization Using Totally Endoscopic Left Internal Mammary Artery Bypass Grafting and Placement of RapamycIN Eluting Stents in the SAme IntervenTIONal Session: the COMBINATION Pilot Study. Cardiology. 2008;110:92-95.
41. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Circulation. 2009;119:1330-1352.
42. Riess FC, Bader R, Kremer P, Kühn C, Kormann J, Mathey D, Moshar S, Tuebler T, Bleese N, Schofer J. Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up. Ann Thorac Surg. 2002;73:1849-1855.
43. Gao C, Yang M, Wang G, Xiao C, Liu H, Lu C. Hybrid coronary revascularization by endoscopic robotic coronary artery bypass grafting on beating heart and stent placement. Ann Thorac Surg. 2009;87:737-741.
44. Cisowski M, Morawski W, Drzewiecki J, Kruczak W, Toczek K, Bis J, Bochenek A. Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg. 2002;22:261-265.
45. Lee MS, Wilentz JR, Makkar RR, Singh V, Nero T, Swistel D, Belsey SJ, Simon C, Rametta S, DeRose J. Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. J Invasive Cardiol. 2004;16:419-425.
46. Us MH, Basaran M, Yilmaz M, Yaymaci B, Ulusoy E, Sanioglu S, Ozbek C, Arslan Y, Pocan S, Yilmaz AT. Hybrid coronary revascularization in high-risk patients. Tex Heart Inst J. 2006;33:458-462.
47. Gilard M, Bezon E, Cornily JC, Mansourati J, Mondine P, Barra JA, Boschat J. Same-day combined percutaneous coronary intervention and coronary artery surgery. Cardiology. 2007;108:363-367.
48. Kon ZN, Brown EN, Tran R, Joshi A, Reicher B, Grant MC, Kallam S, Burris N, Connerney I, Zimrin D, Poston RS. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg. 2008;135:367-375.
49. Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, Reyes PA, Zimrin DA. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: Feasibility, safety, and clinical outcomes. Am Heart J. 2008;155:661-667.
50. Zhao DX, Leacche M, Balaguer JM, Boudoulas KD, Damp JA, Greelish JP, Byrne JG. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization: results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol. 2009;53:232-241.
51. Delhaye C, Sudre A, Lemesle G, Vanesson L, Koussa M, Fayad G, Bauters C, Lablanche JM, Modine T. Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease. Arch Cardiovasc Dis. 2010;103:502-511.
52. Poirier NC, Carrier M, Lesperance J, Ct̂é G, Pellerin M, Perrault LP, Pelletier LC. Quantitative angiographic assessment of coronary anastomoses performed without cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999;117:292-297.
53. Arom KV, Emery RW, Flavin TF, Petersen RJ. Cost-effectiveness of minimally invasive coronary artery bypass surgery. Ann Thorac Surg. 1999;68:1562-1566.
54. Vassiliades T Jr. Enabling technology for minimally invasive coronary artery bypass grafting. Semin Thorac Cardiovasc Surg. 2009;21:237-244.
55. Byrne JG, Leacche M, Vaughan DE, Zhao DX. Hybrid cardiovascular procedures. JACC Cardiovasc Interv. 2008;1:459-468.
56. Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, Fitzgerald D, Hirsh J, Husted S, Kvasnicka J, Montalescot G, García Rodríguez LA, Verheugt F, Vermylen J, Wallentin L, Priori SG, Alonso Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernández Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Morais J, Deckers J, Ferreira R, Mazzotta G, Steg PG, Teixeira F, Wilcox R. Expert consensus document on the use of antiplatelet agents: the Task Force on the Use of Antiplatelet Agents in Patients With Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. Eur Heart J. 2004;25:166-181.
57. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107:2908-2913.
58. Daemen J, Serruys PW. Drug-eluting stent update 2007, part II: unsettled issues. Circulation. 2007;116:961-968.
59. Zimrin D. Hybrid coronary revascularization: antiplatelet and anticoagulant strategies. Presented at TCT; September 21-25, 2010; Washington, DC.
60. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, Higgins RS, Smith CR, Jones RH. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg. 2007;83:921-929.
61. Edwards FH, Peterson ED, Coombs LP, DeLong ER, Jamieson WR, Shroyer ALW, Grover F. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885-892.
62. Herlitz J, Brandrup-Wognsen G, Caidahl K, Haglid M, Karlsson BW, Karlsson T, Albertsson P, Lindelöw B. Mortality and morbidity among patients who undergo combined valve and coronary artery bypass surgery: early and late results. Eur J Cardiothorac Surg. 1997;12:836-846.
63. Thourani VH, Weintraub WS, Guyton RA, Jones EL, Williams WH, Elkabbani S, Craver JM. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation. 2003;108: 298-304.
64. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn LH. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol. 2005;45:14-18.
65. Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper GS, Cohn LH. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach"). Am J Cardiol. 2006;98:1501-1503.
66. Leacche M, Umakanthan R, Zhao DX, Byrne JG. Surgical update: hybrid procedures, do they have a role? Circ Cardiovasc Interv. 2010;3: 511-518.
67. Lytle BW, Cosgrove DM, Taylor PC, Gill CC, Goormastic M, Golding LR, Stewart RW, Loop FD. Reoperations for valve surgery: perioperative mortality and determinants of risk for 1,000 patients, 1958-1984. Ann Thorac Surg. 1986;42:632-463.
68. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363: 1597-1607.
69. Smith CR. Transcatheter aortic valve implantation versus surgical aortic valve replacement in "high risk" patients with aortic stenosis: the randomized PARTNER trial. Presented at: American College of Cardiology Annual Scientific Session/i2 Summit; April 3, 2011; New Orleans, LA.